Literature DB >> 34312226

THAP1 modulates oligodendrocyte maturation by regulating ECM degradation in lysosomes.

Dhananjay Yellajoshyula1, Samuel S Pappas2,3, Abigail E Rogers4, Biswa Choudhury5, Xylena Reed6, Jinhui Ding6, Mark R Cookson6, Vikram G Shakkottai3, Roman J Giger7, William T Dauer8,3,9.   

Abstract

Mechanisms controlling myelination during central nervous system (CNS) maturation play a pivotal role in the development and refinement of CNS circuits. The transcription factor THAP1 is essential for timing the inception of myelination during CNS maturation through a cell-autonomous role in the oligodendrocyte lineage. Here, we demonstrate that THAP1 modulates the extracellular matrix (ECM) composition by regulating glycosaminoglycan (GAG) catabolism within oligodendrocyte progenitor cells (OPCs). Thap1 -/- OPCs accumulate and secrete excess GAGs, inhibiting their maturation through an autoinhibitory mechanism. THAP1 controls GAG metabolism by binding to and regulating the GusB gene encoding β-glucuronidase, a GAG-catabolic lysosomal enzyme. Applying GAG-degrading enzymes or overexpressing β-glucuronidase rescues Thap1 -/- OL maturation deficits in vitro and in vivo. Our studies establish lysosomal GAG catabolism within OPCs as a critical mechanism regulating oligodendrocyte development.

Entities:  

Keywords:  CNS myelination; extracellular matrix; neurodevelopmental disease

Mesh:

Substances:

Year:  2021        PMID: 34312226      PMCID: PMC8346877          DOI: 10.1073/pnas.2100862118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  69 in total

1.  Inhibitors of myelination: ECM changes, CSPGs and PTPs.

Authors:  Danielle E Harlow; Wendy B Macklin
Journal:  Exp Neurol       Date:  2013-11-04       Impact factor: 5.330

Review 2.  Extracellular matrix endocytosis in controlling matrix turnover and beyond: emerging roles in cancer.

Authors:  Elena Rainero
Journal:  Biochem Soc Trans       Date:  2016-10-15       Impact factor: 5.407

3.  Beta-glucuronidase deficiency mucopolysaccharidosis.

Authors:  W S Sly; F E Brot; J Glaser; P D Stahl; B A Quinton; D L Rimoin; W H McAlister
Journal:  Birth Defects Orig Artic Ser       Date:  1974

Review 4.  The extracellular matrix: Focus on oligodendrocyte biology and targeting CSPGs for remyelination therapies.

Authors:  Annie Pu; Erin L Stephenson; V Wee Yong
Journal:  Glia       Date:  2018-03-30       Impact factor: 7.452

5.  Chondroitin sulfates expressed on oligodendrocyte-derived tenascin-R are involved in neural cell recognition. Functional implications during CNS development and regeneration.

Authors:  R Probstmeier; C C Stichel; H W Müller; H Asou; P Pesheva
Journal:  J Neurosci Res       Date:  2000-04-01       Impact factor: 4.164

Review 6.  Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.

Authors:  C Vogler; M S Sands; N Galvin; B Levy; C Thorpe; J Barker; W S Sly
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

7.  Enhancing Oligodendrocyte Myelination Rescues Synaptic Loss and Improves Functional Recovery after Chronic Hypoxia.

Authors:  Fei Wang; Yu-Jian Yang; Nian Yang; Xian-Jun Chen; Nan-Xin Huang; Jun Zhang; Yi Wu; Zhi Liu; Xing Gao; Tao Li; Guang-Qiang Pan; Shu-Bao Liu; Hong-Li Li; Stephen P J Fancy; Lan Xiao; Jonah R Chan; Feng Mei
Journal:  Neuron       Date:  2018-08-02       Impact factor: 17.173

8.  Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans.

Authors:  Tracy L Laabs; Hang Wang; Yasuhiro Katagiri; Thomas McCann; James W Fawcett; Herbert M Geller
Journal:  J Neurosci       Date:  2007-12-26       Impact factor: 6.167

Review 9.  Chondroitin sulfate metabolism in the brain.

Authors:  Dorota Nowicka; Anna Gręda
Journal:  Acta Neurobiol Exp (Wars)       Date:  2019       Impact factor: 1.579

10.  Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning.

Authors:  Lin Xiao; David Ohayon; Ian A McKenzie; Alexander Sinclair-Wilson; Jordan L Wright; Alexander D Fudge; Ben Emery; Huiliang Li; William D Richardson
Journal:  Nat Neurosci       Date:  2016-07-25       Impact factor: 24.884

View more
  1 in total

1.  A pathogenic DYT-THAP1 dystonia mutation causes hypomyelination and loss of YY1 binding.

Authors:  Dhananjay Yellajoshyula; Abigail E Rogers; Audrey J Kim; Sumin Kim; Samuel S Pappas; William T Dauer
Journal:  Hum Mol Genet       Date:  2022-03-31       Impact factor: 5.121

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.